Ultragenyx Pharmaceutical Inc. buy JPMorgan Chase & Co.
Start price
21.11.24
/
50%
€44.00
Target price
21.11.25
€96.83
Performance (%)
-34.09%
End price
22.11.25
€29.00
Summary
This prediction ended on 22.11.25 with a price of €29.00. Massive losses of -34.09% were the result for the BUY prediction by JPMorgan_Chase___Co_. JPMorgan_Chase___Co_ has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -3.933% | -3.933% | -53.022% |
| iShares Core DAX® | -1.034% | -9.171% | -1.558% |
| iShares Nasdaq 100 | -1.947% | -2.616% | 11.249% |
| iShares Nikkei 225® | -0.425% | -9.424% | 24.931% |
| iShares S&P 500 | -1.201% | -2.986% | 7.515% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at JPMorgan Chase & Co. from $105.00 to $102.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.00
27.03.25
27.03.25
€108.68
27.03.26
27.03.26
-52.78%
08:47
08:47
Stopped prediction by JPMorgan_Chase___Co_ for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€19.10
12.03.26
12.03.26
€64.16
12.03.27
12.03.27
-8.38%
08:47
08:47
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.60
27.02.24
27.02.24
€81.12
27.02.25
27.02.25
-17.74%
28.02.25
28.02.25